EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Intercellular nanotube-mediated mitochondrial transfer enhances T cell metabolic fitness and antitumor efficacy

Jeremy G Baldwin, Christoph Heuser-Loy, Tanmoy Saha, Roland C Schelker, Dragana Slavkovic-Lukic, Nicholas Strieder, Inmaculada Hernandez-Lopez, Nisha Rana, Markus Barden, Fabio Mastrogiovanni, Azucena Martín-Santos, Andrea Raimondi und 18 weitere

Cell · 2024-11 · 187 (23) · 6614-6630.e21

DOI: 10.1016/j.cell.2024.08.029 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell, 2024-11. Verfasst von Jeremy G Baldwin und 29 weiteren Autor:innen. Beteiligte Einrichtung: Division of Functional Immune Cell Modulation, Leibniz Institute for Immunotherapy, Regensburg, Germany; Center for Cancer Research, National Cancer …. Hauptthemen laut MEDLINE: Mitochondria, Mice, Inbred C57BL, Nanotubes, CD8-Positive T-Lymphocytes. Die Arbeit wurde bisher 280-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, European Research Council, Else Kroner-Fresenius Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondrial loss and dysfunction drive T cell exhaustion, representing major barriers to successful T cell-based immunotherapies. Here, we describe an innovative platform to supply exogenous mitochondria to T cells, overcoming these limitations. We found that bone marrow stromal cells establish nanotubular connections with T cells and leverage these intercellular highways to transplant stromal cell mitochondria into CD8+ T cells. Optimal mitochondrial transfer required Talin 2 on both donor and recipient cells. CD8+ T cells with donated mitochondria displayed enhanced mitochondrial respiration and spare respiratory capacity. When transferred into tumor-bearing hosts, these supercharged T cells expanded more robustly, infiltrated the tumor more efficiently, and exhibited fewer signs of exhaustion compared with T cells that did not take up mitochondria. As a result, mitochondria-boosted CD8+ T cells mediated superior antitumor responses, prolonging animal survival. These findings establish intercellular mitochondrial transfer as a prototype of organelle medicine, opening avenues to next-generation cell therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitochondriaMice, Inbred C57BLNanotubesCD8-Positive T-LymphocytesAnimalsMiceHumansMesenchymal Stem CellsCell Line, TumorNeoplasmsFemale

Stichwörter der Autor:innen

CAR T therapyCD8(+) T cellsTCR-T therapyTIL therapyTalin 2bone marrow stromal cellscancer immunotherapyimmune metabolismmitochondrial transfernanotubes

Autor:innen und Institutionen

  • Division of Functional Immune Cell Modulation, Leibniz Institute for Immunotherapy, Regensburg, Germany; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Electroni…
  • Division of Functional Immune Cell Modulation, Leibniz Institute for Immunotherapy, Regensburg, Germany.
  • Center for Engineered Therapeutics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA, USA.
  • Division of Functional Immune Cell Modulation, Leibniz Institute for Immunotherapy, Regensburg, Germany; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
  • Next Generation Sequencing Core, Leibniz Institute for Immunotherapy, Regensburg, Germany.
  • Division of Functional Immune Cell Modulation, Leibniz Institute for Immunotherapy, Regensburg, Germany; University of Regensburg, Regensburg, Germany.

Förderung

  • NCI NIH HHS
  • European Research Council
  • Else Kroner-Fresenius Foundation
  • Fondazione AIRC per la ricerca sul cancro ETS
  • Cancer Research Institute
  • Federal Ministry of Education and Research Bonn Office
  • National Cancer Institute
  • Joachim Herz Foundation

Zitieren

APA

Baldwin, J. G., Heuser-Loy, C., Saha, T., Schelker, R. C., Slavkovic-Lukic, D., Strieder, N., Hernandez-Lopez, I., Rana, N., Barden, M., Mastrogiovanni, F., Martín-Santos, A., Raimondi, A., Brohawn, P., Higgs, B. W., Gebhard, C., Kapoor, V., Telford, W. G., Gautam, S., Xydia, M., …, & Gattinoni, L. (2024). Intercellular nanotube-mediated mitochondrial transfer enhances T cell metabolic fitness and antitumor efficacy. Cell, 187(23), 6614-6630.e21. https://doi.org/10.1016/j.cell.2024.08.029

Vancouver

Baldwin JG, Heuser-Loy C, Saha T, Schelker RC, Slavkovic-Lukic D, Strieder N, et al. Intercellular nanotube-mediated mitochondrial transfer enhances T cell metabolic fitness and antitumor efficacy. Cell. 2024;187(23):6614-6630.e21. doi:10.1016/j.cell.2024.08.029

BibTeX
@article{Baldwin2024,
  author = {Baldwin, Jeremy G and Heuser-Loy, Christoph and Saha, Tanmoy and Schelker, Roland C and Slavkovic-Lukic, Dragana and Strieder, Nicholas and Hernandez-Lopez, Inmaculada and Rana, Nisha and Barden, Markus and Mastrogiovanni, Fabio and Martín-Santos, Azucena and Raimondi, Andrea and Brohawn, Philip and Higgs, Brandon W and Gebhard, Claudia and Kapoor, Veena and Telford, William G and Gautam, Sanjivan and Xydia, Maria and Beckhove, Philipp and Frischholz, Sina and Schober, Kilian and Kontarakis, Zacharias and Corn, Jacob E and Iannacone, Matteo and Inverso, Donato and Rehli, Michael and Fioravanti, Jessica and Sengupta, Shiladitya and Gattinoni, Luca},
  title = {Intercellular nanotube-mediated mitochondrial transfer enhances T cell metabolic fitness and antitumor efficacy},
  journal = {Cell},
  year = {2024},
  volume = {187},
  number = {23},
  pages = {6614--6630.e21},
  doi = {10.1016/j.cell.2024.08.029}
}
Kostenlos starten →